Chemours Co current report, 29 September 2021

Business Context and Reporting Period

This Form 8-K is a current report filed by The Chemours Company (Chemours) on September 29, 2021. The filing discloses specific appointments within the company's finance leadership team under Item 5.02.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation arrangements rather than financial performance data.

Material Changes

The material change reported is the restructuring of two senior executive roles within the finance and digital operations divisions:

  • Camela T. Wisel has been appointed Vice President, Chief Accounting Officer and Controller, succeeding Matthew S. Abbott. She previously served as Vice President and Treasurer.
  • Matthew S. Abbott has been appointed Vice President, Digital and Analytics Platforms Leader, transitioning from his role as Vice President, Chief Accounting Officer and Controller.

Guidance, Outlook, and Compensation Details

The filing details the compensatory arrangements for the newly appointed Chief Accounting Officer, Camela T. Wisel:

  • Base Salary: $312,500 annually.
  • Annual Incentive Plan (AIP): Target award of 50% of base salary.
  • Long Term Incentive Plan (LTIP): Target award of $300,000.
  • Benefits: Participation in the Senior Executive Severance Plan and other standard officer benefit plans.

The filing states there are no other arrangements or understandings between Ms. Wisel and other persons in connection with her appointment. No forward-looking guidance or risk factors regarding financial performance are included in this specific report.

Investor Verification Checklist

  • Verify the effective date of the leadership transition between Ms. Wisel and Mr. Abbott.
  • Confirm the total potential annual compensation value for the new Chief Accounting Officer ($312,500 base + $156,250 target AIP + $300,000 target LTIP).
  • Review subsequent filings for any changes to the company's financial reporting structure resulting from these appointments.
  • Check the company's latest 10-Q or 10-K for the actual financial metrics (revenue, profit, cash flow) as they are not contained in this 8-K.